Genmab (GMAB)

Genmab (GMAB) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• GMAB last traded at $55.83, -2.16% on the day.
• Genmab: market cap $35.09B, P/E 43.3, revenue $4.13B over the last four quarters, next earnings 2026-11-05.
• Over the past year GMAB returned 94.73%; year to date 81.27%.

Updated 2026-11-02 17:12 UTC